CME GROUP INC. Quarterly Costs and Expenses in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Cme Group Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2010 to Q3 2024.
  • Cme Group Inc. Costs and Expenses for the quarter ending September 30, 2024 was $560M, a 8.23% increase year-over-year.
  • Cme Group Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $2.2B, a 4.27% increase year-over-year.
  • Cme Group Inc. annual Costs and Expenses for 2023 was $2.14B, a 6.97% increase from 2022.
  • Cme Group Inc. annual Costs and Expenses for 2022 was $2B, a 2.01% decline from 2021.
  • Cme Group Inc. annual Costs and Expenses for 2021 was $2.04B, a 8.98% decline from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $2.2B $560M +$42.6M +8.23% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $2.15B $532M +$10.3M +1.98% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $2.14B $528M +$400K +0.08% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $2.14B $576M +$36.6M +6.78% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $2.11B $518M +$28.6M +5.85% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $2.08B $522M +$34.1M +7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 $2.04B $528M +$40.4M +8.29% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 $2B $540M +$23.9M +4.64% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $1.98B $489M -$7.2M -1.45% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $1.99B $488M -$17M -3.37% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $2B $488M -$40.7M -7.71% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $2.04B $516M -$67.9M -11.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $2.11B $496M -$59.5M -10.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $2.17B $505M -$40.3M -7.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $2.21B $528M -$34M -6.05% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $2.25B $584M +$18.1M +3.2% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 $2.23B $556M -$36.4M -6.15% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $2.26B $545M -$29.3M -5.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $2.29B $562M +$13.6M +2.48% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $2.28B $565M -$21.3M -3.63% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 $2.3B $592M +$238M +67.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $2.06B $574M +$181M +46.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $1.88B $549M +$181M +49% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $1.7B $587M +$224M +61.6% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $1.48B $354M +$31.1M +9.62% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $1.45B $393M +$73.3M +22.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $1.37B $368M +$39.7M +12.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $1.33B $363M -$11.8M -3.15% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-28
Q3 2017 $1.35B $323M +$6.8M +2.15% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-02
Q2 2017 $1.34B $319M -$23.7M -6.91% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 $1.36B $328M -$31.9M -8.85% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2016 $1.39B $375M +$31M +9.01% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $1.36B $316M -$17.5M -5.24% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 $1.38B $343M +$18.2M +5.6% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $1.36B $360M +$24.9M +7.42% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $1.34B $344M -$25.7M -6.95% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 $1.36B $334M +$1.9M +0.57% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 $1.36B $325M +$5.3M +1.66% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $1.36B $335M +$12.5M +3.87% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-04
Q4 2014 $1.34B $370M +$5.8M +1.59% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 $1.34B $332M +$17.9M +5.7% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $1.32B $320M +$11.3M +3.67% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $1.31B $323M +$9.8M +3.13% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 $1.3B $364M +$78.5M +27.5% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-26
Q3 2013 $1.22B $314M +$26.9M +9.37% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-03
Q2 2013 $1.19B $308M -$18.4M -5.63% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-04
Q1 2013 $1.21B $313M -$10.3M -3.19% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 $1.22B $285M -$60.8M -17.6% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-26
Q3 2012 $1.28B $287M -$14.9M -4.93% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 $1.3B $327M +$22.9M +7.54% Apr 1, 2012 Jun 30, 2012 10-Q/A 2013-08-09
Q1 2012 $1.28B $323M +$15.9M +5.17% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 $1.26B $346M +$41.3M +13.6% Oct 1, 2011 Dec 31, 2011 10-K 2014-03-03
Q3 2011 $1.22B $302M +$11.6M +3.99% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 $1.21B $304M +$5M +1.67% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
Q1 2011 $1.2B $308M +$29M +10.4% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-08
Q4 2010 $1.17B $305M Oct 1, 2010 Dec 31, 2010 10-K 2013-03-01
Q3 2010 $291M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09
Q2 2010 $299M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
Q1 2010 $279M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.